Cosmos Health INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Cosmos Health Inc. has issued a proxy statement detailing the agenda for its 2026 Annual Meeting of Stockholders, including director elections, auditor ratification, equity plan approval, and preferred stock issuance.
NASDAQ
Cosmos Health Inc. details its strategic vision, financial performance, and future growth initiatives, including a $300 million digital asset facility and U.S. manufacturing expansion.
NASDAQ
DEF: Cosmos Health Seeks Shareholder Approval for Reverse Split, $300M Notes, and Expanded Equity Plan
Cosmos Health Inc. calls its 2025 Annual Meeting to vote on critical proposals including a discretionary reverse stock split, a $300 million convertible note issuance, and a new 2025 equity incentive plan.
NASDAQ
Cosmos Health Inc. issues a supplement to its proxy statement to correct the number of common shares held by Grigorios Siokas.
NASDAQ
Cosmos Health Inc. is convening its 2024 Annual Meeting of Stockholders to vote on key proposals including director elections, warrant issuance, auditor ratification, an equity incentive plan, and authorization for reverse stock splits.